Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease
<p>Abstract</p> <p>Background</p> <p>Patients with diabetes and ischemic heart disease (IHD) are at high risk for adverse cardiac outcomes. Clinical practice guidelines recommend multiple cardioprotective medications to reduce recurrent events. We evaluated the associat...
Main Authors: | Masoudi Frederick A, Magid David J, Ho P Michael, McClure David L, Rumsfeld John S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-12-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/6/48 |
Similar Items
-
Intracoronary Delivery of Mitochondria to the Ischemic Heart for Cardioprotection.
by: Douglas B Cowan, et al.
Published: (2016-01-01) -
Chrysin restores the cardioprotective effect of ischemic preconditioning in diabetes-challenged rat heart
by: Geetanjali Singh, et al.
Published: (2023-11-01) -
Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart
by: Singh Manjeet, et al.
Published: (2011-07-01) -
The association between processes, structures and outcomes of secondary prevention care among VA ischemic heart disease patients
by: Magid David J, et al.
Published: (2006-02-01) -
The Ambivalence of Connexin43 Gap Peptides in Cardioprotection of the Isolated Heart against Ischemic Injury
by: Aleksander Tank Falck, et al.
Published: (2022-09-01)